Compare RACE & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RACE | BDX |
|---|---|---|
| Founded | 1947 | 1897 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.2B | 51.5B |
| IPO Year | 2015 | 1994 |
| Metric | RACE | BDX |
|---|---|---|
| Price | $334.32 | $159.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $488.14 | $189.60 |
| AVG Volume (30 Days) | 699.0K | ★ 2.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 1.01% | ★ 2.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.34 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $7.64 | N/A |
| Revenue Next Year | $7.41 | $2.53 |
| P/E Ratio | ★ $34.59 | $122.22 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $328.00 | $160.89 |
| 52 Week High | $519.10 | $231.82 |
| Indicator | RACE | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 35.33 | 23.22 |
| Support Level | $328.00 | N/A |
| Resistance Level | $381.03 | $195.22 |
| Average True Range (ATR) | 7.58 | 4.23 |
| MACD | -3.93 | -1.10 |
| Stochastic Oscillator | 0.73 | 4.32 |
Ferrari designs, engineers, and manufactures some of the world's most expensive luxury cars. With supply carefully controlled to be below demand and a brand steeped in decades of motor racing history, a Ferrari is viewed as a status symbol. In 2025, the company sold 13,640 vehicles at an average price over EUR 500,000 with more than 80% of its vehicles being sold to existing Ferrari clients. Eighty-four percent of revenue is generated from the sale of cars and spare parts and 10% from sponsorship, commercial, and brand activities including racing and lifestyle activities. In 2025, the Europe, Middle East, and Africa region accounted for 49% of revenue, the Americas was 32%, mainland China, Hong Kong, and Taiwan was 7%, and the rest of Asia was 12%.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.